蚯蚓纤溶酶的分离纯化及部分序列的测定

以新鲜蚯蚓为原料,经过保温抽提、乙醇沉淀、DEAE-SepharoseFastFlow离子交换层析、Lysine-Sepharose4B亲和层析以及SDS-PAGE制备电泳等纯化步聚,得到一种纯度达95％以上的蚯蚓纤溶酶．该酶具有强烈的溶解纤维蛋白的作用及蛋白酶活性,平板法测得其比活性为90OUK单位／毫克蛋白,TAME法测得其比活性为2500O单位／毫克蛋白．酶学性质研究表明其最适反应温度为65℃,最适反应PH值为8．5．该酶的分子量为33kD,等电点为pH3．5．还对该酶进行了氨基酸组成分析,并测定了其N端部分序列．     

磁共振体素内不相干运动扩散加权成像在肺癌所致肺不张影像诊断中的初步应用

目的:探讨磁共振体素内不相干运动扩散加权成像(intravoxel incoherent motion diffusion weighted MR Imaging,IVIM-DWI)在肺癌所致肺不张的影像诊断中的初步应用。方法:选取独立肺段肺不张病变患者43例,其中肺癌致肺不张31例(肺癌组),局部炎症致肺不张12例(炎症组)。所有患者在药物治疗或手术前均行3.0T磁共振IVIM-DWI检查,b值取0、50、100、200、400、600、800、1000 s/mm~2,分别测量灌注分数(perfusion fraction,f)、真实扩散系数(diffusion coefficient,D)以及关注相关扩散系数(diffusion coefficient from the perfused compartment,D*),对上述参数值进行相关统计学分析,并依据受试者工作特征曲线(Receiver Operating Characteristic,ROC)对各参数的评价效能进行分析。结果:肺癌组的D值、D*值以及f值分别为(0.64±0.16)×10~(-3)mm~2/s、(19.77±6.16)×10~(-3)mm~2/s以及(29.62±9.74)%,而炎症组的D值、D*值以及f值分别为(0.67±0.14)×10~(-3) mm~2/s、(21.14±8.32)×10~(-3)mm~2/s以及(47.62±11.46)%;经比较,肺癌组D值、D*值与炎症组无统计学差异(P0.05),而二者f值差异显著,有统计学意义(P0.01)。f值最佳阈值为38.42%,此时曲线下面积(Area Under Curve,AUC)为0.94,诊断肺癌的特异度为0.89,敏感度为0.93,阳性预测值为0.92,阴性预测值为0.89。结论:磁共振IVIM-DWI技术在肺癌所致肺不张的影像诊断中具有一定的应用价值。     

The ART and science of sperm mitophagy

This article discusses the historical perspective and the new findings of autophagy and ubiquitin-proteasome system cooperation during the post-fertilization sperm mitophagy, a process that eliminates potentially damaged paternal mitochondrial DNA from an early embryo. New insight into the mechanism that promotes clonal, maternal inheritance of mitochondrial genes may be helpful for managing mitochondrial disease and infertility in humans, as well as reproductive performance and production traits in agriculturally important domestic animals.     

Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

The prognostic significance of KIT mutations in core-binding factor acute myeloid leukemia (CBF-AML), including inv(16) and t(8;21) AML, is uncertain. We performed a systematic review and meta-analysis of the effect of KIT mutations on the complete remission (CR) and relapse rates and overall survival (OS) of CBF-AML. PubMed, Embase, Web of Science, and the Cochrane Library were searched and relevant studies were included. Negative effect was indicated on relapse risk of CBF-AML (RR [relative risk], 1.43; 95%CI [confidence interval], 1.20–1.70) and t(8;21) AML (RR, 1.70; 95% CI, 1.31–2.21), not on OS of CBF-AML (RR, 1.09; 95% CI, 0.97–1.23), CR (OR [odds ratio], 0.95; 95% CI, 0.52–1.74), relapse risk (RR, 1.12; 95% CI, 0.90–1.41) or OS (RR, 1.03; 95% CI, 0.90–1.18) of inv(16) AML. Subgroup analysis of t(8,21) AML showed negative effect of KIT mutations on CR (OR, 2.03; 95%CI: 1.02–4.05), relapse risk (RR, 1.89; 95%CI: 1.51–2.37) and OS (RR, 2.26; 95%CI: 1.35–3,78) of non-Caucasians, not on CR (OR, 0.61; 95%CI: 0.19–1.95) or OS (RR, 1.12; 95%CI: 0.90–1.40) of Caucasians. This study indicates KIT mutations in CBF-AML to be included in the initial routine diagnostic workup and stratification system of t(8,21) AML. Prospective large-scale clinical trials are warranted to evaluate these findings.     

H102对转基因AD小鼠脑内NF-κB信号通路相关蛋白的影响

目的：研究β片层阻断肽H102对转基因AD小鼠脑内NF-κB通路相关蛋白活性及表达的影响。方法：将30只8周龄APP/PS1双转基因小鼠随机分为模型组和给药组,另选15只同周龄同背景的C57BL/6J小鼠设为对照组（n=15）。给药组每日经鼻腔给予H102溶液5 μl （5.8 mg/kg）,对照组和模型组每日给予等量空白辅料溶液。给药16周后,采用Morris水迷宫检测小鼠的空间参考记忆变化,采用免疫组织化学方法和免疫印迹技术测定小鼠脑组织内β样淀粉样蛋白（Aβ_1-42）、核因子-κB （NF-κB）、核因子-κB抑制蛋白（IκB）、IκB蛋白激酶（IKK）及其磷酸化蛋白（p-NF-κB、p-IκB、p-IKK）以及诱导型一氧化氮合酶（iNOS）和活化型半胱天冬酶-3（cleaved Caspase 3）蛋白的表达。结果：①Morris水迷宫测试：模型组小鼠的空间学习记忆能力较对照组显著降低,给药组较模型组显著提高（P<0.05）。②免疫组化及免疫印迹检测结果模型组小鼠脑组织内Aβ_1-42、p-IKK、p-NF-κB、p-IκB、核内NF-κB及iNOS和cleaved Caspase 3蛋白的表达较对照组显著增高,给药组蛋白表达较模型组显著降低（P<0.05）。结论：H102可抑制APP/PS1双转基因小鼠脑内NF-κB信号转导通路,抑制细胞凋亡和炎症反应,明显改善转基因AD小鼠的学习记忆能力。     

Natural Progression of Canine Glycogen Storage Disease Type IIIa

Glycogen storage disease type IIIa (GSD IIIa) is caused by a deficiency of glycogen debranching enzyme activity. Hepatomegaly, muscle degeneration, and hypoglycemia occur in human patients at an early age. Long-term complications include liver cirrhosis, hepatic adenomas, and generalized myopathy. A naturally occurring canine model of GSD IIIa that mimics the human disease has been described, with progressive liver disease and skeletal muscle damage likely due to excess glycogen deposition. In the current study, long-term follow-up of previously described GSD IIIa dogs until 32 mo of age (n = 4) and of family-owned GSD IIIa dogs until 11 to 12 y of age (n = 2) revealed that elevated concentrations of liver and muscle enzyme (AST, ALT, ALP, and creatine phosphokinase) decreased over time, consistent with hepatic cirrhosis and muscle fibrosis. Glycogen deposition in many skeletal muscles; the tongue, diaphragm, and heart; and the phrenic and sciatic nerves occurred also. Furthermore, the urinary biomarker Glc₄, which has been described in many types of GSD, was first elevated and then decreased later in life. This urinary biomarker demonstrated a similar trend as AST and ALT in GSD IIIa dogs, indicating that Glc₄ might be a less invasive biomarker of hepatocellular disease. Finally, the current study further demonstrates that the canine GSD IIIa model adheres to the clinical course in human patients with this disorder and is an appropriate model for developing novel therapies.Abbreviations: CCR, curly-coated retriever; CPK, creatine phosphokinase; GSD IIIa, glycogen storage disease type IIIa; Glc₄, Glcα1-6Glcα1-4Glcα1-4GlcGlycogen storage disease type IIIa (GSD IIIa; OMIM, 232400) is an autosomal recessive disorder caused by mutations in the glycogen debranching enzyme gene (AGL), leading to various clinical signs. The tissues mainly affected are liver, heart, and skeletal muscle. Clinical manifestations include hypoglycemia, elevated serum concentrations of liver and muscle enzymes, hepatomegaly, growth retardation, muscle weakness, cardiac hypertrophy with arrhythmia risk, polycystic ovaries and neuropathy.^15,17,29 Current treatments are mainly symptomatic and are not curative. The most frequently used therapies are dietary, such as providing uncooked corn starch to prevent hypoglycemia at young ages and high-protein diets, which have been shown to reverse the extent of cardiomyopathy associated with GSD IIIa.^7,8,30,37 In addition, the use of medium-chain triglycerides has shown positive therapeutic effects in patients with GSD Ia and GSD IIIa.^11,22 However, dietary therapies do not prevent the long-term complications of GSD IIIa, including hepatic cirrhosis, hepatocellular adenoma, hepatocellular carcinoma, cardiomyopathy, neuropathy, and myopathy.³¹An appropriate animal model is necessary to test novel therapies and address the long-term effects of GSD IIIa. Recently a mouse model for GSD III has been described that may prove beneficial in testing new therapies.¹⁹ However, the limitations of mouse models include a short lifespan that curtails the study of the long-term effects of novel treatments. In addition, a large animal model often mimics human disease more closely than do mouse models, as occurs in GSD type Ia dog models, which exhibit lactic acidosis similar to human patients, a characteristic that mouse models of GSD Ia lack.¹⁶ Therefore a naturally occurring large animal model for GSD IIIa may be more effective in terms of the development of new treatments than are available mouse models.GSD IIIa (OMIA, 001577) has been reported to occur in curly-coated retriever dogs (CCR) and is caused by a naturally occurring homozygous frameshift mutation in exon 32 that leads to the deletion of 126 amino acids at the C-terminus of glycogen debranching enzyme.^12,40 The dogs in these previous studies proved to have abnormalities similar to those seen in humans affected with the disorder, namely progressive glycogen accumulation in muscle and liver, elevated liver and muscle enzymes (ALP, AST, creatine phosphokinase [CPK], and ALT), and eventual liver fibrosis. However, these animals were not followed beyond 16 mo of age in the earlier studies.^12,40 The goal of the current study is to provide biochemical follow-up on these animals and analyze more extensively other tissues and organs involved in GSD IIIa in the dog model. A brief analysis of the naturally high protein diets of GSD IIIa dogs, as well as the effects of an increased protein diet in 2 dogs for the last few months of life, is included.We also include the analysis of a urinary biomarker, Glcα1–6Glcα1– 4Glcα1–4Glc (Glc₄), which is a breakdown product of glycogen by α-amylase and neutral α-1,4-glucosidase.³² Elevated levels of Glc₄ have been found in urine from patients with GSD types II, III, IV, VI, and IX and may correlate with disease advancement.^1,18,24,32 To our knowledge, Glc₄ has not been evaluated previously in dogs; we therefore here evaluated the utility of Glc₄ as a biomarker of canine GSD IIIa. A correlation of Glc₄ levels with liver enzyme concentrations in blood might indicate a role of Glc₄ as a less-invasive biomarker for determining the advancement of liver disease in human and canine patients.     

两类植物型沙丘上植物群落的异同及其对沙丘形态的响应

为探究相同环境条件下发育的两类植物型沙丘上植物群落的异同点,以及相异点与沙丘形态的关系,对毛乌素沙地南缘盐碱地上相间分布的抛物线形沙丘和白刺灌丛沙丘分别进行形态学、植物群落学及土壤理化性质的调查分析。结果显示:抛物线形沙丘的水平尺度虽为白刺灌丛沙丘的12-23倍,但两类沙丘上物种数相当,其植物分属12科31属39种和12科30属33种,均以菊科、藜科、禾本科、豆科植物为主(占70%以上),其中共有植物17种,群落相似度0.66;两类沙丘上的群落建群种不同,优势种的重叠度较低,抛物线形沙丘的不同部位共统计到7个植物群丛,可分为沙生植物群落和喜湿耐盐碱群落,白刺灌丛沙丘上均以白刺为建群种,油蒿、冰草、雾冰藜、沙蓬、狗尾草为主要优势种;沙丘形态造成其不同部位风沙活动及土壤水分、PH值和全盐含量的差异是两类沙丘上植物群落相异的重要影响因素。     

降雨和汇流对黑土区坡面土壤侵蚀的影响试验研究

东北黑土区上坡汇流对坡面土壤侵蚀有重要影响,因此辨析降雨和汇流对黑土区坡面土壤侵蚀的影响对农田土壤侵蚀防治有重要意义。通过设计不同降雨强度和汇流速率以及二者组合的模拟降雨及上方汇流试验,分析了降雨和汇流对黑土坡面侵蚀的影响及其贡献。试验处理包括两个降雨强度(50 mm/h和100 mm/h)、两个汇流速率(50 mm/h和100 mm/h,即:10 L/min和20 L/min)、以及4种不同降雨强度和汇流速率的组合((50+50)mm/h、(50+100)mm/h、(100+50)mm/h和(100+100)mm/h)。结果表明,在50 mm/h和100 mm/h上方汇流引起的坡面侵蚀量仅分别是50 mm/h和100 mm/h降雨引起坡面侵蚀量的1.9%和0.6%;当降雨强度和坡上方汇流速率分别由50 mm/h增加至100 mm/h时,降雨试验处理下的坡面侵蚀量增加6.1倍,汇流试验处理下的坡面侵蚀量增加3.2倍,说明降雨对坡面土壤侵蚀的影响显著大于汇流的作用。在降雨和汇流组合试验中,总供水强度(降雨强度+汇流速率)为150 mm/h时,降雨强度为100 mm/h和汇流速率为50 mm/h组合试验的坡面侵蚀量是降雨强度为50 mm/h和汇流速率为100 mm/h组合试验坡面侵蚀量的7.9倍。在相同汇流条件下,降雨强度由50 mm/h增加到100 mm/h时,降雨强度的增加对坡面侵蚀量的贡献率为89.6%-99.5%;而在相同降雨条件下,坡面汇流速率由50 mm/h增加100 mm/h时,汇流速率的增加对坡面侵蚀量的贡献率为17.2%-78.7%,说明在东北黑土区防治坡面汇流对坡面土壤侵蚀影响也尤为重要。     

Elevated auxin and reduced cytokinin contents in rootstocks improve their performance and grafting success

Plant grafting is an important technique for horticultural and silvicultural production. However, many rootstock plants suffer from undesirable lateral bud outgrowth, low grafting success rates or poor rooting. Here, we used a root‐predominant gene promoter (SbUGT) to drive the expression of a tryptophan‐2‐monooxygenase gene (iaaM) from Agrobacterium tumefaciens to increase auxin levels in tobacco. The transgenic plants, when used as a rootstock, displayed inhibited lateral bud outgrowth, enhanced grafting success rate and improved root initiation. However, root elongation and biomass of SbUGT::iaaM transgenic plants were reduced compared to those of wild‐type plants. In contrast, when we used this same promoter to drive CKX (a cytokinin degradation gene) expression, the transgenic tobacco plants displayed enhanced root elongation and biomass. We then made crosses between the SbUGT::CKX and SbUGT::iaaM transgenic plants. We observed that overexpression of the CKX gene neutralized the negative effects of auxin overproduction on root elongation. Also, the simultaneous expression of both the iaaM and CKX genes in rootstock did not disrupt normal growth and developmental patterns in wild‐type scions. Our results demonstrate that expression of both the iaaM and CKX genes predominantly in roots of rootstock inhibits lateral bud release from rootstock, improves grafting success rates and enhances root initiation and biomass.     

Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma

Background

Numerous recent studies indicate that the long non-coding RNAs (lncRNAs) are frequently abnormal expressed and take critical roles in many cancers. Renal cell carcinoma is the secondary malignant tumors in the urinary system and has high mortality and morbidity. Around 80% of RCCs is clear cell renal cell carcinoma (ccRCC) and is characterized by high metastasis and relapse rate. However, the clinical significances of lncRNAs in ccRCC are still unknown.

Methods

The human cancer lncRNA PCR array (Yingbio) was performed to detect the differentially expressed lncRNAs in human ccRCC samples. Real-time PCR (RT-PCR), dual-luciferase assay, RNA binding protein immunoprecipitation (RIP) assay, transwell assay, CCK-8 assay, and western blot were performed to explore the molecular mechanism of lncRNAs in ccRCC cell migration and invasion.

Results

In this study, lncRNA-H19 was high expressed and negatively correlated with miR-29a-3p in ccRCC. By bioinformatics software, dual-luciferase reporter and RIP assays, we verified that miR-29a-3p was identified as a direct target of lncRNA-H19. RT-PCR and western blot demonstrated that down-regulated lncRNA-H19 could affect the expression of miR-29a-3p targeting E2F1 with competitively binding miR-29a-3p. Furthermore, transwell assays indicated that lncRNA-H19 knockdown inhibited cells migration and invasion, but this effect was attenuated by co-transfection of lncRNA-H19 siRNA and miR-29a-3p inhibitor. Over expression of E2F1 could rescue lncRNA-H19 siRNA induced suppression on cell migration and invasion in ccRCC cells.

Conclusions

These results show a possible competing endogenous RNAs regulatory network involving lncRNA-H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in ccRCC. This mechanism may contribute to a better understanding of ccRCC pathogenesis, and lncRNA-H19 may be further considered as a potential therapeutic target for ccRCC intervention.